Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors. Raheem SJ, Bashyal S, Haj-Mirzaian A, Khazaei Monfared Y, et al. J Nucl Med 2025 Nov 20:jnumed.125.270568. doi: 10.2967/jnumed.125.270568.

Read + Share

Amedeo Smart

Independent Medical Education

Raheem SJ, Bashyal S, Haj-Mirzaian A, Khazaei Monfared Y, et al. Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors. J Nucl Med 2025 Nov 20:jnumed.125.270568. doi: 10.2967/jnumed.125.270568.
PMID: 41266253